Sveriges mest populära poddar
JAMA Clinical Reviews
Hälsa och motionMedicin

Managing Adverse Effects of Obesity Medications

12 min•29 juli 2025

New medications for obesity, such as semaglutide and tirzepatide, are highly effective but can be associated with adverse effects that reduce adherence. Obesity expert and author Robert Kushner, MD, joins JAMA Deputy Editor Mary McDermott, MD, to discuss a recent JAMA Insights article on managing adverse effects of obesity medications.

Related Content:

-----------------------------------

JAMA Editors' Summary

Fler avsnitt av JAMA Clinical Reviews

Visa alla avsnitt av JAMA Clinical Reviews
Evaluating for Pediatric Concussion
•16 min
Iron Deficiency in Adults: Advances in Diagnosis and Treatment
•17 min
From the JAMA Network: Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging
•15 min
Resistant Hypertension: Diagnosis and Management
•18 min
Update on Peanut Allergy
•19 min
Obesity-Related Cancer
•21 min
Diagnosis and Treatment of Chronic, Noninfectious Diarrhea
•20 min
Does This Patient Have Volume Overload? The Rational Clinical Examination
•19 min
Type 1 Diabetes: Diagnosis and Management
•17 min
Pharmaceutical Pricing: JAMA Talks With Mark Cuban
•33 min

JAMA Clinical Reviews med JAMA Network finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.